CARA Has been consolidating for over 5 years now and is flirting with its ATH.
The promising biotech company only has a market cap of 11B which makes a 5x move very easy and fast. This is more of a longer-term play and can increase well over 5x
Stock may dip before the meteoric rise but hard to say with earnings coming first week of August.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.